With the development of molecular bio-medicine, many BC-related molecules have been explored, and the most commonly used markers in clinical practice include human epidermal growth factor receptor-2 (HER2), estrogen receptor (ER), progesterone receptor (PR), and Ki67 [5,6]. Here, ERBB2 is linked to breast cancer.